An overwhelming number of Australian physicians who prescribe biologics believe the TGA should insist on distinct non-proprietary scientific names for all biosimilars and reference products, a survey reveals. However the 160 respondents of the online survey conducted by the Alliance for Safe Biologic Medicines (ASBM) were divided on whether biosimilars should receive an identifying prefix, ...
Biologic prescribers united on need for naming convention
By Nicola Garrett
23 Feb 2017